GlycoVaxyn raised €629k in a Series A round in Jul 2006. The company is based in Switzerland. Investors in the round: Index Ventures, Sofinnova Partners. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
